Header Logo

Connection

Magda Shaheen to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications Magda Shaheen has written about TOR Serine-Threonine Kinases.
Magda Shaheen
Connection Strength
0.044
TOR Serine-Threonine Kinases
  1. Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA. Cell Death Dis. 2020 12 11; 11(12):1052.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.